Literature DB >> 28056634

Relating cause of death with place of care and healthcare costs in the last year of life for patients who died from cancer, chronic obstructive pulmonary disease, heart failure and dementia: A descriptive study using registry data.

Annicka Gm van der Plas1,2,3, Mariska G Oosterveld-Vlug1,2,3, H Roeline W Pasman1,2,3, Bregje D Onwuteaka-Philipsen1,2,3.   

Abstract

BACKGROUND: The four main diagnostic groups for palliative care provision are cancer, chronic obstructive pulmonary disease, heart failure and dementia. But comparisons of costs and care in the last year of life are mainly directed at cancer versus non-cancer or within cancer patients. AIM: Our aim is to compare the care and expenditures in their last year of life for Dutch patients with cancer, chronic obstructive pulmonary disease, heart failure or dementia.
DESIGN: Data from insurance company Achmea (2009-2010) were linked to information on long-term care at home or in an institution, the National Hospital Registration and Causes of Death-Registry from Statistics Netherlands. For patients who died of cancer ( n = 8658), chronic obstructive pulmonary disease ( n = 1637), heart failure ( n = 1505) or dementia ( n = 3586), frequencies and means were calculated, Lorenz curves were drawn up and logistic regression was used to compare patients with high versus low expenditures.
RESULTS: For decedents with cancer and chronic obstructive pulmonary disease, the highest costs were for hospital admissions. For decedents with heart failure, the highest costs were for the care home (last 360 days) and hospital admissions (last 30 days). For decedents with dementia, the highest costs were for the nursing home.
CONCLUSION: Patients with dementia had the highest expenditures due to nursing home care. The number of dementia patients will double by the year 2030, resulting in even higher economic burdens than presently. Policy regarding patients with chronic conditions should be informed by research on expenditures within the context of preferences and needs of patients and carers.

Entities:  

Keywords:  Healthcare expenditures; Netherlands; costs of dying; end-of-life care; hospital costs; long-term care; population ageing

Mesh:

Year:  2017        PMID: 28056634     DOI: 10.1177/0269216316685029

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  6 in total

1.  The Association between Quality Improvement Initiatives in Dementia Care and Supportive Psychosocial Work Environments in Nursing Homes.

Authors:  Miharu Nakanishi; Maki Tei-Tominaga
Journal:  Healthcare (Basel)       Date:  2018-05-08

2.  Burden of Healthcare Utilization among Chronic Obstructive Pulmonary Disease Patients with and without Cancer Receiving Palliative Care: A Population-Based Study in Taiwan.

Authors:  Li-Ting Kao; Kuo-Chen Cheng; Chin-Ming Chen; Shian-Chin Ko; Ping-Jen Chen; Kuang-Ming Liao; Chung-Han Ho
Journal:  Int J Environ Res Public Health       Date:  2020-07-10       Impact factor: 3.390

3.  Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study.

Authors:  Audrey Tanguy-Melac; Dorian Verboux; Laurence Pestel; Anne Fagot-Campagna; Philippe Tuppin; Christelle Gastaldi-Ménager
Journal:  Eur J Health Econ       Date:  2021-06-07

Review 4.  Exploring costs, cost components, and associated factors among people with dementia approaching the end of life: A systematic review.

Authors:  Javiera Leniz; Deokhee Yi; Emel Yorganci; Lesley E Williamson; Trisha Suji; Rachel Cripps; Irene J Higginson; Katherine E Sleeman
Journal:  Alzheimers Dement (N Y)       Date:  2021-09-14

5.  Adaptation of the Ambulatory and Home Care Record for collecting palliative care service utilisation data from family carers in the UK: a pilot study.

Authors:  Laura M Holdsworth; Heather Gage; Peter Williams; Claire Butler
Journal:  Pilot Feasibility Stud       Date:  2018-08-18

6.  Palliative Care in the Global Setting: ASCO Resource-Stratified Practice Guideline.

Authors:  Hibah Osman; Sudip Shrestha; Sarah Temin; Zipporah V Ali; Rumalie A Corvera; Henry D Ddungu; Liliana De Lima; Maria Del Pilar Estevez-Diz; Frank D Ferris; Nahla Gafer; Harmala K Gupta; Susan Horton; Graciela Jacob; Ruinuo Jia; Frank L Lu; Daniela Mosoiu; Christina Puchalski; Carole Seigel; Olaitan Soyannwo; James F Cleary
Journal:  J Glob Oncol       Date:  2018-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.